Status:
COMPLETED
Predictor of Advanced Subclinical Atherosclerosis
Lead Sponsor:
PreMD
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
40-80 years
Brief Summary
Evaluation of skin cholesterol for cardiovascular risk assessment in asymptomatic individuals at low, intermediate, or high risk based on Framingham Global Risk estimates. Carotid intima-media thickne...
Detailed Description
This study will enroll 600 asymptomatic subjects at low (\<6%), intermediate (6-20% ), or high (\>20%) 10-year Framingham global cardiovascular risk in approximately equal proportions. Subjects will ...
Eligibility Criteria
Inclusion
- Informed written consent from the subject prior to testing.
- Males or females 40-80 years of age
Exclusion
- Subjects taking cholesterol-lowering medications
- Known hepatitis
- Known pregnancy
- Skin disease on either hand (e.g. eczema psoriasis, rash or broken skin)
- Known CAD (previous myocardial infarction, coronary revascularization procedure), cerebrovascular disease (previous stroke, transient ischemic attack, or carotid revascularization procedure), or peripheral arterial disease(claudication or previous revascularization procedure)
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
End Date :
May 1 2006
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00245284
Start Date
September 1 2005
End Date
May 1 2006
Last Update
June 6 2006
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Radiant Research
Chicago, Illinois, United States, 60610
2
University of Chicago
Chicago, Illinois, United States, 60637
3
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21224
4
University of Minnesota
Minneapolis, Minnesota, United States, 55415-1226